Literature DB >> 10964636

Using entertainment television to build a context for prevention news stories.

C P Cooper1, D L Roter, A M Langlieb.   

Abstract

UNLABELLED: OBJECTIVE. A nationally syndicated television news series called "Following ER" was developed to educate viewers about the health issues dramatized on "ER," NBC's award-winning medical drama. This study investigated the impact of this prime-time link on viewer attention, satisfaction, information recall, and perceptions about the uses and gratifications delivered by a news story.
METHODS: A total of 458 municipal jurors participated in a randomized 2 ("ER" tie-in vs no tie-in) x 2 (familiar vs novel story topic) experiment. The four experimental news stories required by this design were developed using footage of previously aired local newscasts.
RESULTS: In the case of the familiar topic story, the "ER" tie-in enhanced the attention and satisfaction of viewers. Participants reported that the prime-time link added value by elevating the importance and relevance of the commonplace topic. However, the "ER" tie-in did not generate any beneficial effects when paired with the novel topic story.
CONCLUSIONS: Framing news stories about familiar health concerns in the context of television drama represents a viable strategy for legitimizing them as important and timely topics for public consumption and debate. Copyright 2000 American Health Foundation and Academic Press.

Entities:  

Mesh:

Year:  2000        PMID: 10964636     DOI: 10.1006/pmed.2000.0706

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  2 in total

1.  Local television news coverage of traumatic deaths and injuries.

Authors:  D L McArthur; D Magaña; C Peek-Asa; J F Kraus
Journal:  West J Med       Date:  2001-12

Review 2.  Behavioral Interventions for Stroke Prevention: The Need for a New Conceptual Model.

Authors:  Joel Salinas; Lee H Schwamm
Journal:  Stroke       Date:  2017-05-09       Impact factor: 7.914

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.